Bhubaneswar: Siksha ‘O’ Anusandhan Deemed to be University (SOA) in Bhubaneswar will join hands with US-based THINQ Pharma and Ayurvidya Healthcare Innovations to carry out research on developing drugs from natural and synthetic products to treat difficult diseases.
SOA announced this after a discussion between its founder president Prof Manojranjan Nayak and eminent scientist and president and chief scientific officer of THINQ Pharma and Ayurvidya Healthcare Innovations Mukund S Chorghade on Saturday.
A team of researchers comprising scientists from THINQ Pharma and different disciplines of SOA including pharmacy, biotechnology, medical sciences and engineering will be constituted to develop new drugs and drug products from natural and synthetic origin.
Chorghade was accompanied by Dr Debendra Kumar Mohapatra, Chief Scientist, CSIR-Indian Institute of Chemical Technology, Hyderabad.
Chorghade is a Fellow of the American Chemical Society (ACS) and is known for the discovery of sterically protected and electronically activated metallporphyrin catalysts called ‘chemosynthetic artificial livers’ which help in drug metabolism, valorisation of biomass and environmental remediation.
Bhubaneswar: The Bhubaneswar Municipal Corporation (BMC) on Monday announced that the Patha Utsav, which was…
Hyderabad: Bhaskar, husband of the 35-year-old woman who died in the Sandhya Theatre stampede in Hyderabad,…
Koraput: Vigilance has apprehended a Marketing Inspector for taking a bribe of Rs 7,000 from…
Mumbai: Legendary filmmaker Shyam Benegal breathed his last at Wockhardt Hospital in Mumbai on Monday.…
Mumbai: Chief Minister Devendra Fadnavis on Monday came down heavily on Leader of Opposition Rahul…
Baripada: More than 60 participants took part in the 15th edition of the Mayurbhanj Heritage Walk…
This website uses cookies.